b'Scientific Session Abstracts SUNDAY APRIL 21, 2024Table: Adjusted Hazard Ratios (aHRs) For One-Year Mortalityafter in-hospital stroke or in-hospitalCEA TFCAS TCARStroke vs. No Stroke Stroke vs. No Stroke Stroke vs. No StrokeaHR (95% CI) p-value aHR (95% CI) p-value aHR (95% CI) p-valueAll patients 5.9 (5.1-6.8) 0.001 4.2 (3.7-5.3) 0.001 5.2 (4.1-6.5) 0.001Symptomatic 4.9 (3.9-6) 0.001 4.3 (3.1-5.7) 0.001 4 (2.9-5.6) 0.001Asymptomatic 7.1 (5.8-8.8) 0.001 4 (2.7-5.8) 0.001 6.8 (5-9.1) 0.001MI vs. No MI MI vs. No MI MI vs. No MIaHR (95% CI) p-value aHR (95% CI) p-value aHR (95% CI) p-valueAll patients 3.8 (3.1-4.6) 0.001 3.5 (2.3-5.5) 0.001 5.1 (3.6-7.2) 0.001Symptomatic 3 (2.2-4.1) 0.001 4.2 (2.6-6.7) 0.001 4.9 (3-8.1) 0.001Asymptomatic 4.5 (3.5-5.6) 0.001 2.4 (0.9-6.5) 0.098 5.1 (3.3-8.1) 0.001TCAR vs. CEA TCAR vs. CEA TCAR vs. CEAAfter in- (CEA is ref.) (CEA is ref.) (CEA is ref.)hospital StrokeaHR (95% CI) p-value aHR (95% CI) p-value aHR (95% CI) p-valueAll patients 0.93(0.73-1.2) 0.55 1.5(1.1-2.1) 0.003 0.7(0.55-0.94) 0.015Symptomatic 1.1(0.7-1.5) 0.81 1.7(1.1-2.5) 0.013 0.6(0.34-0.85) 0.004Asymptomatic 0.8(0.6-1.3) 0.3 1.3(0.8-2) 0.3 0.95(0.6-1.5) 0.82After in- aHR (95% CI) p-value aHR (95% CI) p-value aHR (95% CI) p-valuehospital MIAll patients 1.4 (0.9-2.3) 0.1 2.3 (1.2-4.2) 0.007 0.7 (0.36-1.5) 0.3Symptomatic 1.6 (0.93-3.5) 0.2 3.9 (1.8-8.3) 0.001 0.6 (0.2-0.9) 0.116Asymptomatic 1 (0.6-1.8) 0.9 0.95 (0.3-2.7) 0.9 1.6 (0.5-4) 0.3* Adjusting for the following confounders: age, gender, race, ethnicity, obesity, dialysis, diabetes, hypertension, smoking, CAD, prior CHF, COPD, CABG/PCI, prior contralateral CEA/CAS, ipsilateral occlusion, prior ipsilateral CEA/CAS, procedure urgency, anesthesia, ASA class, preoperative medications, insurance42 NDANNUAL MEETING|APRIL 1921, 2024|OCEANSIDE, CA 93'